Learn More
Apexbio Technology LLC PSI-6206 5mg

Supplier: Apexbio Technology LLC A81895
PSI-6206 (CAS 863329-66-2) is a small-molecule inhibitor targeting the Hepatitis C Virus (HCV) NS5B RNA polymerase It is designed to inhibit this viral enzyme thereby disrupting HCV RNA synthesis PSI-6206 exerts its biological activity primarily through inhibition of RNA synthesis mediated by the HCV NS5B polymerase following intracellular conversion to its triphosphate form (RO2433-TP) In HCV replicase assays PSI-6206 demonstrates an IC50 value of 1 19 M and in recombinant Con1 NS5B protein studies it has an IC50 of 0 52 M (Ki 0 141 M) Based on these pharmacological properties PSI-6206 holds research potential in HCV replication studies and antiviral drug candidate evaluation
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.